Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Performances of Soluble Fibrin Assay in Exclusion of Pulmonary Embolism and Deep Venous Thrombosis

NCT02523937 is registered in ClinicalTrials.gov with Diagnostica Stago R&D as lead sponsor.

NCT NCT02523937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02523937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Performances of Soluble Fibrin Assay in Exclusion of Pulmonary Embolism and Deep Venous Thrombosis
Lead sponsor
Diagnostica Stago R&D
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
July 31, 2018
Enrollment
863 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis (dvt), pulmonary embolism (pe)